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1. Introduction
Wnts compromise a large family of secreted glycoproteins that have shown to be part of the
signaling molecules that regulate several aspects of development such as axis formation and
midbrain development [1, 2]. In mammals at least 19 Wnt members have been found. The
interaction of a Wnt protein with members of the Frizzled (Fz) family of seven-pass trans‐
membrane cell-surface receptors triggers the activation of the Wnt signaling pathway [3-5]. In
human and mice, 10 members of the Fz family have been identified. In addition, receptor-like
tyrosine kinase (Ryk) and receptor tyrosine kinase-like orphan receptor (Ror2) have been
identified as alternative Wnt receptors [6-8]. Different Wnt signaling cascades are activated
downstream the Wnt receptors, identified as Wnt/β-catenin or canonical pathway, and β-
catenin-independent or non-canonical pathways. The canonical pathway involves the tran‐
scription of Wnt target genes, while activation of non-canonical Wnt pathways may induce
either an increase in intracellular calcium concentration or activation of the c-Jun-N-terminal
kinase (JNK) cascade [3, 9, 10].
The Wnt pathway participates in the development of the central nervous system (CNS) and
growing evidence indicate that Wnts also regulates the function of the adult nervous system
[11, 12]. In fact, most of the key components including Wnts and Fz receptors are expressed in
the adult brain [13, 14]. Wnt ligands have shown to regulate synaptic assembly as well synaptic
plasticity and neurotransmission [15-20], and more recently it has also been involved in the
adult neurogenesis [21-25].
Deregulation of the Wnt signaling has been associated to several pathologies, been cancer the
most widely documented [26-28]. More recently, altered Wnt signaling have been related to
mental disorders, mood disorders and neurodegenerative diseases [12, 29-32].
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In the first part of this chapter we will address what is currently known about the signaling
cascades of canonical and non-canonical pathways. Then, we will review recent findings
from our and other labs on the specific effects of different Wnt ligands on the structure of
pre-  and  postsynaptic  regions  and  on  glutamatergic  neurotransmission  in  hippocampal
neurons.  The  synaptic  role  of  some  Fz  receptors  will  also  be  reviewed.  Finally,  the
neuroprotective effect of the Wnt signaling activation will be discussed mainly focused on
the protection against the toxicity of Aβ-peptide aggregates associated to the pathogene‐
sis of Alzheimer’s disease.
2. The Wnt signaling pathway: Canonical and non–canonical signaling
cascades
The binding of Wnt ligands to Fz receptors can trigger the activation of different signaling
cascades. In addition to Fz, other proteins have been described as alternative receptors or co-
receptors, such as the low-density lipoprotein receptor-related protein 5 (LRP5), LRP6, Ror1,
Ror2 and Ryk [3, 33-36], increasing the complexity of the Wnt signaling activation. It has been
suggested that the binding of Wnts to specific receptors/co-receptors may selectively activate
distinct signaling pathways.
The  first  Wnt  signaling  pathway  identified  was  the  canonical  Wnt/β-catenin  pathway
(Figure 1). In the absence of Wnt stimulation, the levels of cytoplasmic β-catenin are low
since  it  is  ubiquitinated  and  constantly  degraded  in  the  proteasome  [37].  β-catenin  is
phosphorylated by casein kinase 1α (CK1α) and glycogen synthase kinase-3β (GSK-3β) in
a  multiprotein  complex  composed  also  of  the  scaffold  protein  axin  and  adenomatous
polyposis coli (APC) [38-42]. Phosphorylated β-catenin is recognized by β-TrCP, which is
part of an E3 ubiquitin ligase complex, and is ubiquitinated and subsequently degraded
[43]. Activation of the Wnt/β-catenin pathway initiated by the binding of a Wnt ligand to
a Fz receptor and coreceptors LRP5/6 activates the protein Dishevelled (Dvl)  usually by
phosphorylation, and triggers the recruitment of axin to the phosphorylated tail  of LRP,
inhibiting the degradation pathway consequently inducing the cytoplasmic stabilization of
β-catenin which enters the nucleus and regulates the transcription of Wnt target genes [28].
Recently, it was shown that when the destruction complex is associated with phosphorylat‐
ed LRP, it  may still  capture and phosphorylates β-catenin,  but ubiquitination is blocked
(Figure 1, right panel) [44].
In the nucleus, β-catenin binds to members of the family of T-cell factor (Tcf) and lymphoid
enhancer factor (Lef) [45-47]; this binding displaces Groucho, which is bound to Tcf/Lef and
recruits histone deacetylases (HDAC) to repress the transcription of Wnt target genes [48-51].
Several Wnt target genes have been identified including c-Myc, cyclin D1, Axin2, Calcium/
calmodulin-dependent protein kinase type IV (CamKIV) [52-55]. In addition, by using an in silico
analysis based on multiple Classification and Regression Tree (CART), 89 new genes were
predicted to be targets of the Wnt/β-catenin pathway [56].
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Figure 1. Canonical Wnt/β-catenin signaling pathway. (Left panel) In the absence of a Wnt protein, GSK-3β phos‐
phorylates β-catenin which targets it for ubiquitination by β-TrCP and degradation in the proteasome. (Right panel)
Activation of the signaling pathway by the binding of a Wnt ligand to Fz receptor and coreceptors LRP5/6 triggers the
association of the destruction complex with phosphorylated LRP. In this condition, the complex may still capture and
phosphorylate β-catenin, however the ubiquitination is blocked and it is stabilized in the cytoplasm and enters the
nucleus to regulate the transcription of Wnt target genes.
There  are  at  least  two  β-catenin-independent  pathways:  the  planar  cell  polarity  (PCP)
pathway and the Ca2+  pathway (Figure 2). The PCP pathway was originally identified in
Drosophila  where  it  regulates  tissue  polarity  and  cell  migration  [10,  57].  This  signaling
pathway requires Fz receptors and Dvl and activates small GTPases including Rho and Rac
and the protein kinase JNK. This pathway is also known as the Wnt/JNK pathway. The
activation of  the  Wnt/Ca2+  pathway triggers  the  increase  in  intracellular  Ca2+  levels  and
activates  the  protein  kinases  CamKII  and  protein  kinase  C  (PKC)  [10,  58].  It  has  been
suggested  that  Wnt-mediated  Ca2+  release  involves  heterotrimeric  G  proteins  since  it  is
inhibited by pertussis toxin [59]. As mentioned 10 Fz receptors are known in mammals. Fz
receptors are seven-transmembrane-spanning receptors that belong to the G protein-cou‐
pled receptor (GPCR) list as a separate class [60]. Fz receptors have an extracellular amino-
terminal region that contains a cysteine-rich domain (CRD) consisting of 120 to 125 residues
with 10 conserved cysteines that is relevant for the binding of Wnt proteins [61]. Growing
evidence indicate the involvement of G protein in the Wnt/Fz signaling. The first evidence
came from inhibition of non-canonical Wnt effects by pertussis toxin [62]. Later on, many
reports  have  indicated  that  heterotrimeric  G  protein  participates  of  canonical  and  non-
canonical Wnt signaling in Drosophila, Xenopus and mammals [63-69].
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Figure 2. β-catenin-independent Wnt signaling pathways. In the Wnt/JNK pathway or PCP pathway, a Wnt ligand
through a Fz receptors and Dvl activates small GTPases including Rho and Rac and JNK, which in turns modulate cytos‐
keletal organization. The activation of the Wnt/Ca2+ pathway triggers an increase in intracellular Ca2+ levels which acti‐
vates CamKII and PKC.
3. Roles of the Wnt signaling pathway at central synapses
The Wnt signaling pathway has different roles during development linked to neurite pattern‐
ing and synaptogenesis. Different Wnt ligands have been linked to the presynaptic assembly.
In 1997, Salinas and co-workers demonstrated in cerebellar neurons that Wnt-7a increases the
levels of synapsin I, a protein associated to synaptic vesicles [70]. Moreover, Wnt-7a mutant
mice show a delay in the accumulation of synapsin I [71]. In hippocampal neurons Wnt-7a as
well as Wnt-3a and Wnt-7b increases the number of pre-synaptic puncta suggesting a role for
these ligands in presynaptic assembly [18, 72, 73]. In addition, Wnt-7a was found to stimulate
recycling and endocytosis of synaptic vesicles using FM dyes [74]. In hippocampal neurons,
Wnt-7a was also able to increase the expression as well as the clustering of the α7- nicotinic
acetylcholine receptor (α7-nAChR), indicating that the Wnt signaling regulates the clustering
of presynaptic receptors [75]. Interestingly, all these ligands are able to modulate presynaptic
differentiation by activation of the Wnt/β-catenin signaling pathway, suggesting that some of
the components associated with this pathway may be involved in the presynaptic effect. On
the other hand, the non-canonical ligand Wnt-5a decreases the number of presynaptic
Trends in Cell Signaling Pathways in Neuronal Fate Decision118
terminals [72], indicating that canonical and non-canonical signaling pathways may have
promoting and inhibitory effects on presynaptic differentiation respectively. In accordance,
electrophysiological recordings on adult rat hippocampal slices showed that Wnt-7a, but not
Wnt-5a, increased neurotransmitter release in CA3-CA1 synapses by decreasing paired pulse
facilitation and increasing the frequency of miniature excitatory postsynaptic currents
(mEPSC) [73]. Also, Wnt-7a/Dvl1 double mutant mice exhibit decreased mEPSC frequency at
the mossy fiber-granule cell synapse revealing a defect in neurotransmitter release [18].
The Wnt signaling also plays relevant roles in the postsynaptic structure. Wnt-5a, which
activates non-canonical Wnt signaling cascades in hippocampal neurons [19, 76], modulates
postsynaptic assembly by increasing the clustering of the postsynaptic density protein-95
(PSD-95) and increases spine morphogenesis in cultured hippocampal neurons [15, 19]. PSD-95
is a scaffold protein of the postsynaptic density (PSD), which is a multiprotein complex that
interacts with key molecules involved in the regulation of glutamate receptor targeting and
trafficking and regulatory proteins relevant for neurotransmission [77, 78]. In hippocampal
neurons, Wnt-5a induces a fast increase in the number of clusters of PSD-95 without affecting
total levels of PSD-95 protein or presynaptic protein clustering [19]. This postsynaptic effect is
dependent on Wnt/JNK signaling pathway as demonstrated by using JNK inhibitors. In long-
term experiments, we observed that Wnt-5a is also able to increase the total number of synapses
[79]. When hippocampal neurons were incubated with the formylated hexapeptide Foxy-5,
which is derived from the sequence of Wnt-5a and mimics the full Wnt-5a molecule action in
neurons and other systems [19, 80], there was an increase in PSD-95 since 1 hour, but after 24
hours an increase in the synaptic vesicle protein 2 (SV2) clustering was also observed. In
consequence, there was an increase in the total number of synaptic contacts [79].
Also, we determined that Wnt-5a induced a transient formation of dendrite protrusions that
resulted in a net increase of mature dendrite spines. Videomicroscopy revealed that Wnt-5a
induced de novo formation of dendritic spines and also increased the size of the preexisting
ones [15]. Interestingly, treatment with the soluble CRD region of Fz2, acting as a Wnt
scavenger, decreased spine density in cultured neurons, supporting the physiological rele‐
vance of this finding and supporting the implication of Wnt ligands in dendrite spine mor‐
phogenesis. Wnt-7a is also able to increase the density and maturity of dendritic spines through
a CamKII-dependent mechanism [81]. Wnt-7a rapidly activates CaMKII in spines and
inhibition of this kinase abolishes the effects of Wnt-7a on spine growth and excitatory synaptic
strength. This finding implicates the Wnt/Ca2+ signaling cascade in synaptic effects of Wnt
ligands. Interestingly, Wnt-5a and Wnt-7a induces an increase in intracellular Ca2+ concentra‐
tion [15, 81], supporting the activation of this non-canonical Wnt pathway.
In addition to the structural effects of Wnt ligands at the excitatory synapse, different Wnts
have shown modulatory effects on glutamatergic neurotransmission. Wnt-3a modulates the
recycling of synaptic vesicles in hippocampal synapses [73, 82] and is able to induce an increase
in the frequency of mEPSC [20]. In hippocampal slices, blockade of Wnt signaling impairs long-
term potentiation (LTP), whereas activation of Wnt signaling facilitates LTP [17]. In the case
of Wnt-5a, acute application of this ligand in hippocampal slices increases the amplitude of
field excitatory postsynaptic potentials (fEPSP) and upregulates synaptic NMDA receptor
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currents facilitating induction of LTP [15, 16]. Interestingly, Wnt-5a produced a two-step
increase in the amplitude of NMDAR responses [16]. The mechanisms involved in this two-
step effect of Wnt-5a were investigated by the delivery of specific protein kinase inhibitors via
the recording pipette. Specifically, the role of PKC and JNK was investigated, since these are
two known downstream kinases of the non-canonical pathway. Inhibition of Ca22+-dependent
PKC isoforms with Go6976 or the more general PKC inhibitor calphostin C eliminated the first
step of potentiation of NMDAR currents and did not affect the second one. On the contrary,
the slower developing increase in NMDAR currents was blocked by the JNK inhibitors TI-
JIP153-163 and SP600125. This indicate that there are two mechanisms involved in in the
potentiation of NMDAR by Wnt-5a. There is a fast PKC-dependent potentiation and a slower
JNK-dependent potentiation that does not require previous activation of PKC [16].
Wnt-5a also regulates postsynaptically the hippocampal inhibitory synapses [76]. Wnt-5a
induces surface expression and maintenance of GABAA receptor in the membrane of hippo‐
campal neurons, increases the amplitude of GABA-currents due to a postsynaptic mechanisms,
and induces the recycling of functional GABAA receptors through activation of CaMKII [76].
Therefore Wnt-5a is able to modulate both, excitatory and inhibitory synapses which must be
relevant for neurotransmission.
The novel role for Wnt ligands in synaptic transmission provides a mechanism for Wnt
signaling to acutely modulate synaptic plasticity and brain function in later stages of devel‐
opment and in the mature organism. Importantly, neuronal activity modulates the release and
expression of Wnt ligands which may be relevant for the function of these ligands during
neurotransmission. Activation of NMDA receptors increases the expression of Wnt-2 in
hippocampal neurons which then stimulates dendritic arborization [83]. On the other hand,
tetanic stimulation induce NMDA receptor-dependent synaptic Wnt3a release [17]. The role
for endogenous Wnts was supported by incubation of hippocampal slices with secreted Wnt
inhibitors, such as secreted Frizzled-related protein-2 (sFRP-2), which showed that endoge‐
nous Wnt ligands are modulators of glutamatergic neurotransmission being necessary to
maintain basal NMDA receptor synaptic transmission [15, 16].
The in vivo relevance for the role of Wnt signaling in activity-mediated synaptic connectivity
was revealed in mice exposed to an enriched environment (EE). These animals showed
increased complexity and number of large mossy fiber terminals in the CA3 region [84]. EE
increased Wnt7a/b levels in CA3 pyramidal neurons and inhibiting Wnt signaling through
locally applied sFRP-1, suppressed the effects of EE on synapse numbers and further reduced
synapse numbers in control mice.
These findings show that Wnt ligands are important regulators of the synaptic structure during
development and in adult neurons, and that the Wnt pathway is one of the signaling cascades
regulated by neuronal activity that is involved in the regulation of neurotransmission in adult
nervous system.
In addition to the role of Wnts, Fz receptor have also been involved in synaptic structure and
function. In the hippocampus, we have determined that different Fz receptors have very
different patterns of expression during development, being some of them highly expressed in
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adulthood and others during early development [85]. In addition, the distribution of Fzs in
hippocampal neurons is also very specific. Some receptors, are located in the synaptic region,
while others are mainly located in the soma or in the growth cones of young neurons [85].
These findings suggest that these receptors could be important regulators for the specific
activation of the Wnt signaling cascades during the development of hippocampal circuits. In
fact, we determined an association of the distribution with specific functions. In hippocampal
neurons, Fz1 is located in the synaptic region co-localizing with presynaptic proteins and with
active synaptic vesicle recycling sites [82]. Interestingly, overexpression of Fz1 increased the
number of clusters of Bassoon, a component of the active zone involved in the structural
organization of neurotransmitter release sites that is recruited early during synapse formation
[86], suggesting that Fz1 regulates synaptic differentiation. In agreement, treatment with the
extracellular CRD of Fz1 decreased Bassoon clustering which was not observed with the CRD
of Fz2, indicating a receptor specificity for the synaptic effect [82]. Fz5 also has a role in mature
neurons where it modulates the synaptogenic effect of Wnt7a [87]. As well as Fz1, Fz5 is present
in synaptosomes and colocalizes with synaptic markers, and changes in the expression of this
receptor modulates the density of synaptic sites [87]. In addition to its function in mature
neurons, Fz5 was shown to be in high levels in the growth cones of developing hippocampal
neurons [85], and we have recently determined that this receptor is involved in neural
polarization (unpublished results). We determined that overexpression of Fz5 triggers a
mislocalization of axonal proteins such as Tau-1 and phosphorylated MAP1B (MAP1BP),
which change their distribution to the whole cell suggesting altered polarization. When the
expression of Fz5 is knocked-down by shRNA, MAP1BP is not polarized and is almost
completely lost. These findings suggest that in developing hippocampal neurons Fz5 is
relevant for neural polarization. These studies indicate that Fz receptors are relevant players
in both the developing and the adult nervous system and support the notion that the Wnt
signaling pathway is crucial for different aspects of the development and function of the CNS.
4. Role of Wnt signaling in adult neurogenesis
In the adult brain, there are two regions where there is a continuous generation of new neurons
(Figure 3A), the subventricular zone (SVZ) of the lateral ventricles [88] and the subgranular
zone (SGZ) in the hippocampal dentate gyrus [89]. In the SVZ, astrocyte-like neural stem cells
(NSCs), called type B1 cells, generate type C cells that rapidly proliferate and give rise to type
A neuroblasts (Figure 3B). These cells migrate through the rostral migratory stream to the
olfactory bulb where they became interneurons [88] (Figure 3A). In the SGZ, radial and non-
radial neural precursor cells give rise to transient amplifying progenitors that generate
neuroblasts and then became immature neurons that extend dendrites toward the molecular
layer and project their axons through the hilus toward the CA3 region [90] (Figure 3C).
Newborn neurons then mature and fully integrate into the preexisting hippocampal circuitry.
Adult neurogenesis is highly regulated by intrinsic and extrinsic mechanisms. Many signaling
pathways have been identified as regulators of different aspects of neurogenesis. Notch, Shh,
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BMPs, and Wnts are part of the signaling molecules of the niche that regulate the maintenance,
activation and fate specification of neural precursor cells [91, 92].
In Wnt/β-catenin reporter mice (BATGAL) it was shown that this pathway is active in the SGZ
and the dentate granule cell layer [23]. In that study, authors determined that Wnt3 is expressed
in adult hippocampal astrocytes and that adult hippocampal progenitor (AHP) cells express
key components of the Wnt/β-catenin signaling pathway. These findings suggested that the
Wnt pathway may be involved in the regulation of adult neurogenesis. In vitro analysis in
cultured cells revealed that Wnts derived from hippocampal astrocytes stimulate Wnt/β-
catenin signaling in isolated AHPs inducing their neuronal commitment [23]. The effect of the
Wnt signaling was supported in vivo using lentiviral vectors expressing Wnt3a or a secreted
mutant Wnt1 protein that blocks Wnt signaling. Lentiviruses were stereotactically injected into
the dentate gyrus of rats. As assessed by the incorporation of the nucleotide analog BrdU and
immunodetection of the immature neuron protein doublecortin (DCX), blocking the Wnt
signaling decreases adult hippocampal neurogenesis while stimulating this pathway has the
opposite effect [23]. More recently, and by using the same lentiviral approach to block Wnt
signaling in the dentate gyrus of adult rats it was shown that Wnt-mediated adult hippocampal
neurogenesis contributes to learning and memory [93]. In the SVZ, β-catenin signaling also
plays a role in the proliferation of progenitor cells in the adult mouse brain [94]. Retrovirus-
mediated expression of a stabilized β-catenin promoted the proliferation of type C cells and
inhibited their differentiation into neuroblasts. Also in the SVZ, transduction of the β-catenin
inhibitor axin by intracranial lentiviral delivery decreased cell proliferation as revealed by
decreased BrdU labeling [95], further supporting a role for Wnt/β-catenin signaling in neural
stem cell proliferation in the neurogenic areas of adult brain.
The Wnt-mediated effects in neurogenesis may be caused by the transcriptional activation of
NeuroD1 which is dependent on the Wnt/β-catenin signaling activation [25]. NeuroD1 is a
basic helix-loop-helix transcription factor important for the generation of granule cell and
olfactory neuron in the embryonic and adult brain [96]. NeuroD1 gene promoter has overlap‐
ping DNA-binding site for Sox2 and TCF/LEF, then the activation of this gene implies
activation of the canonical Wnt pathway and removal of Sox2 repression from the NeuroD1
gene promoter [25]. More recently, Prox1 was also determined as a target of the Wnt/β-catenin
pathway relevant for neurogenesis [22]. Prox1 is expressed in newborn and mature granule
cells and is required for the proper differentiation and survival of newborn granule cells, but
not for the maintenance of granule cells after they have fully matured [22].
In addition, Wnts could indirectly modulate adult neurogenesis thorough their effects on
neuronal  activity.  As previously described,  different  Wnts regulate glutamatergic  neuro‐
transmission,  and  evidence  indicates  that  neural  progenitor  cells  respond  to  neuronal
activity as part of their differentiation program [97]. GABA is an important modulator of
adult  hippocampal  neurogenesis  being critical  for  the  proper  development  and matura‐
tion of  adult-born neurons [98-100].  Interestingly,  Wnt-5a through activation of  CaMKII,
induces  the  recycling  of  functional  GABAA  receptors  on  hippocampal  neurons  and
modulates inhibitory synapses [76].
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As mentioned, in neurogenic niches Wnts are provided by astrocytes [23], and during aging
it was reported that the levels of Wnt3 protein and the number of Wnt3-secreting astrocytes
declines [101], which may be one of the factors underlying the impairment of neurogenesis
that is observed in aging [102, 103]. On the contrary, running, that is a potent stimulator of
adult neurogenesis in the SGZ [104] was found to significantly increase de novo expression of
Wnt-3 [101], pointing to the Wnt pathway as one of the factors involved in running-mediated
increase in neurogenesis. In addition to astrocytes-derived Wnts, an autocrine Wnt signaling
activity has been observed in adult hippocampal progenitors (AHPs) derived from adult rat
Figure 3. Neurogenesis in the adult brain. (A) Schematic representation of adult rodent brain highlighting the two
neurogenic regions. The hippocampus and the SVZ (boxed). (B) Schematic of the SVZ in the wall of the lateral ventri‐
cles. Distinct stem/progenitor cell types (types B, C, and A) are shown. (C) Neurogenesis in the SGZ of the hippocampal
dentate gyrus. The progression of radial type 1 cells to mature newborn granule neurons is schematized.
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brains. Inhibiting this autocrine Wnt signaling increases the number of neurons formed and
leads to a loss of multipotency among AHPs indicating that this autocrine pathway may
preserve the balance between neural stem cell maintenance and differentiation [105].
The Wnt signaling has also been involved in the mechanism of the orphan nuclear receptor
TLX (also known as NR2E1), which is an important regulator of neural stem cell maintenance
and self-renewal in embryonic and adult brains [106, 107] and is involved in neurogenesis in
the SVZ [108] and hippocampus [109]. To stimulate neural stem cell proliferation and self-
renewal TLX activates the Wnt/β-catenin pathway in adult mouse neural stem cells by
activating the expression of Wnt-7a, which expression was found to be downregulated in TLX-
null mice, through binding to two TLX binding sites present in the Wnt-7a gene promoter [95].
Wnt-7a is important for adult neural stem cell proliferation in vivo since there is a decreased
BrdU labeling in the SGZ and SVZ of adult Wnt7a knockout mice. In TLX-/- mice, intracranial
lentiviral transduction of active β-catenin led to a considerable rescue of cell proliferation in
the SVZ, suggesting that Wnt/β-catenin acts downstream of TLX to regulate neural stem cell
proliferation in vivo [95].
It has been shown that low oxygen is associated with increased levels of β-catenin in vivo, and
that hypoxia inducible factor-1α (HIF-1α) modulates the Wnt/β-catenin signaling in embryonic
stem cells exposed to low oxygen [110]. Recently, we determined in vivo that hypoxia stimulates
the activation of the Wnt/β-catenin signaling pathway in the hippocampus of adult mice (our
unpublished results), and stimulates cell proliferation in the SGZ of 2 month old wild-type
mice.
Altogether, these findings indicate that the Wnt pathway is relevant not only for the develop‐
ment of the nervous system but also for the development of new neurons in the adult brain,
being important for the maintenance and self-renewal of the stem cell pool and for the
commitment and proliferation of new neurons.
5. Wnt signaling in Alzheimer’s disease
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by a progressive
deterioration of cognitive abilities, cerebral accumulation of extracellular amyloid plaques
composed mainly of amyloid-β peptide (Aβ), and synaptic alterations [111]. In addition to the
accumulation of Aβ aggregates, which is a product of the processing of the amyloid precursor
protein (APP), cytoskeletal alterations associated to the abnormal phosphorylation of the
microtubule associated protein tau [112, 113] are early manifestations that lead to aberrant
remodeling of dendrites and axons, the appearance of dystrophic neurites, synaptic loss [114],
and eventually progressive loss of neuronal populations [112].
During more than a decade, a strong relationship between an impaired Wnt signaling pathway
activity and neuronal damage in AD has been raised [31, 115-118]. Different studies have
shown that Wnt signaling components are altered in AD [119-124], and in addition, the Wnt
signaling pathway has been related to other neurodegenerative disorders such as autism and
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schizophrenia [30, 125]. Among the Wnt components that are affected in AD, it was shown
that β-catenin levels are reduced in AD patients carrying presenilin-1 (PS-1)-inherited
mutations [124], while the secreted Wnt antagonist Dickkopf-1 (Dkk1) is elevated in postmor‐
tem AD brains and brains from transgenic mouse models for AD [121, 126]. A variant of the
LRP6 has been associated with late-onset AD, which confers low levels of Wnt signaling [119].
In addition, genetic studies show a link between Wnt signaling and AD. Epidemiological data
show an increased risk for AD in populations where the allele 4 of apo-lipoprotein E (apoE4)
is present. Interestingly apoE4 causes inhibition of the canonical Wnt signaling in PC12 cells
upon stimulation with Wnt-7a as determined by luciferase activities and nuclear β-catenin
levels [127]. Aβ directly binds to the extracellular CRD of Fz5 at or in close proximity to the
Wnt-binding site inhibiting the canonical Wnt signaling pathway [128], linking directly Aβ to
Wnt impairment. Moreover, the exposure of cultured rat hippocampal neurons to Aβ results
in inhibition of canonical Wnt signaling as determined by destabilization of endogenous levels
of β-catenin, increase in GSK-3β activity, and a decrease in the expression of some Wnt target
genes [129]. Moreover, acute exposure to Aβ increases Dkk1 mRNA levels in hippocampal
brain slices, which seems to be associated to synaptic loss induced by Aβ [130].
As mentioned, one of the hallmarks of AD brains is the abnormal phosphorylation of the tau
protein which accumulates as intraneuronal neurofibrillary tangles [131]. Several kinases can
phosphorylate tau in vitro; however, the bulk of the information supports that Cdk5, extrac‐
ellular signal-related kinase 2, microtubule affinity-regulating kinase and GSK-3β, a key
component of the Wnt cascade, are the most relevant kinases for tau phosphorylation in vivo
[132, 133]. Cultured neurons exposed to Aβ show an increased GSK-3β activity [134, 135], and
active GSK-3β has been found in brains staged for AD neurofibrillary changes, with a con‐
comitant decrease in β-catenin levels and an increase in tau hyperphosphorylation [136]. Also,
neurodegeneration and spatial learning deficits have been observed in GSK-3β conditional
transgenic mice [137, 138]. Interestingly, a study shows that the phosphorylation of tau
antagonizes apoptosis by stabilizing β-catenin; therefore, up-regulation of β-catenin during
tau phosphorylation prevents the cell from going into apoptosis. Increasing levels of phos‐
phorylated tau was correlated with increased levels of nuclear β-catenin, and the knockdown
of β-catenin antagonizes the anti-apoptotic effects of tau [139]. These findings support a role
of β-catenin as a survival element in AD.
Several studies have shown neuroprotective properties of the Wnt signaling activation against
the toxicity of Aβ peptide. In cultured hippocampal neurons, exposure to Aβ aggregates causes
a decrease in endogenous β-catenin levels, and this effect was overcome by direct activation
of the pathway with Wnt-3a conditioned media [117, 129]. The protective effect of Wnt-3a
against the toxicity of Aβ oligomers was shown to be mediated by Fz1 receptor, since this effect
is modulated by the expression levels of Fz1 in both, PC12 cells and hippocampal neurons [14].
Overexpression of Fz1 significantly increased cell survival induced by Wnt-3a and diminished
caspase-3 activation, while knocking-down the expression of the receptor by antisense
oligonucleotides decreased the stabilization of β-catenin induced by Wnt-3a and decreased the
neuroprotive effect elicited by this Wnt ligand [14].
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In agreement with the effect of Wnt-3a, inhibition of GSK-3β by lithium protects hippocampal
neurons from Aβ-induced damage. More importantly, in vivo lithium treatment of double
transgenic APPswe/PSEN1ΔE9 mice, which is a well characterized in vivo model of AD that
shows most hallmarks of the disease [140], reduced spatial memory impairment, decreased
Aβ oligomers and the activation of astrocytes and microglia [141]. In vivo, lithium treatment
activated the Wnt signaling as shown by the increase in β-catenin and by the inhibition of
GSK-3β [141]. These studies suggest that the loss of normal Wnt/β-catenin signaling activity
may be involved in the Aβ-dependent neurodegeneration observed in AD and that the
activation of the pathway might have beneficial effects for the treatment of the disease [12].
APPswe/PSEN1ΔE9 mice show decreased levels of adult neurogenesis [142]. In these mice, we
evaluated the effect of hypoxia on the generation of new neurons in the hippocampus. As
previously mentioned hypoxia induces the activation of the Wnt/β-catenin signaling pathway
in the hippocampus of wild-type mice. Mice were exposed to low oxygen and neurogenesis
was evaluated by incorporation of BrdU and double staining with DCX. It was determined
that hypoxia is a strong stimulator of neurogenesis in AD mice (our unpublished results).
Currently we are evaluating whether this effect is related to the activation of the canonical Wnt
pathway. Also, we have observed that voluntary wheel running strongly increased neuro‐
genesis in APPswe/PSEN1ΔE9 mice and also decreased Aβ burden and tau phosphorylation
(our unpublished results). As previously mentioned, voluntary running was found to increase
de novo expression of Wnt-3 [101], suggesting that the effects observed in runner AD mice could
involve the activation of the Wnt signaling pathway.
In addition to the role of the canonical Wnt signaling, we have studied whether Wnt-5a is able
to protect neurons against Aβ oligomers synaptotoxicity [143]. Synaptic failure is an early event
in AD, and soluble Aβ oligomers are proposed to be responsible for the synaptic pathology
that occurs before the plaque deposition and neuronal death [74, 144]. Electrophysiological
analysis of Schaffer collaterals-CA1 glutamatergic transmission in hippocampal slices dem‐
onstrated that Wnt-5a prevents the decrease in the amplitude of fEPSP and EPSCs induced by
Aβ oligomers, indicating that Wnt-5a prevents the synaptic damage triggered by Aβ [143].
Moreover, Wnt-5a prevented the decrease in the postsynaptic density scaffold protein PSD-95
and synaptic loss in cultured hippocampal neurons [143], supporting that Wnt-5a improves
synaptic function in the presence of Aβ.
Additionally, the activation of several signaling pathways that crosstalk with the Wnt pathway
also supports the neuroprotective potential of the Wnt cascades in AD [12].
6. Conclusions
As we have discussed throughout this Chapter, the Wnt signaling pathway has fundamental
roles in the development and function of the CNS. As discussed, the canonical and non-
canonical Wnt signaling cascades have shown to be important for the formation and structure
of central synapses, and in addition to the structural effects, Wnt ligands acutely modulate
synaptic transmission and plasticity. Also, in the adult brain the Wnt pathway is one of the
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signaling cascades that regulates the generation of new neurons in neurogenic niches.
Importantly, different stimuli that regulate neurogenesis involve the regulation of the Wnt
signaling, implicating this pathway as a relevant player in the modulation of this physiological
process.
Considering all the discussed roles of Wnts, it was expected that alterations in the Wnt cascades
leads to diseases associated to the nervous system. In fact, deregulation of the Wnt pathway
has been related to mental disorders, mood disorders and neurodegenerative diseases. As we
have discussed, a bulk of evidence associate Wnt dysfunction to AD, and strongly point to a
neuroprotective potential of the Wnt cascades as a therapeutic approach. Future work should
focus on explore the therapeutic benefits of stimulating the Wnt signaling pathway in vivo.
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